
CME Group Inc.: updates and filings
Price
$306.31
November 19, 2026Market cap $110B
What Ploutos Investor adds for CME
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Oct 21, 2026next Jan 22, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
October 2026
September 2026
July 2026
June 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Oct 23, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Oct 21, 2026Results of operationsForm8-K
- Sep 25, 2026Amended articles or bylawsForm8-K
- Sep 9, 2026Officer or director changeForm8-K
- Aug 11, 2026Regulation FD disclosureForm8-K
- Jul 24, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Jul 22, 2026Results of operationsForm8-K
- Jun 17, 2026Officer or director change, Regulation FD disclosureForm8-K
- Jun 10, 2026Shareholder voteForm8-K
- May 19, 2026Additional annual meeting materialFormDEFA14A
- May 19, 2026Shareholder voteForm8-K
- Apr 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Apr 27, 2026Material agreement enteredForm8-K
- Apr 24, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- Apr 22, 2026Results of operationsForm8-K
- Apr 16, 2026Additional annual meeting materialFormDEFA14A
- Mar 26, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 23, 2026Additional annual meeting materialFormDEFA14A
- Mar 23, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Mar 23, 2026Annual meeting proxy statementFormDEF 14A
- Mar 13, 2026Shares registered for employeesFormS-8
- Mar 12, 2026Additional annual meeting materialFormDEFA14A
- Mar 12, 2026Preliminary proxy statementFormPRE 14A
- Mar 5, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Feb 26, 2026Annual reportfor the period to Dec 31, 2025Form10-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Oct 23, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Oct 21, 2026 | 8-K | Results of operations | Document |
| Sep 25, 2026 | 8-K | Amended articles or bylaws | Document |
| Sep 9, 2026 | 8-K | Officer or director change | Document |
| Aug 11, 2026 | 8-K | Regulation FD disclosure | Document |
| Jul 24, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Jul 22, 2026 | 8-K | Results of operations | Document |
| Jun 17, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Jun 10, 2026 | 8-K | Shareholder vote | Document |
| May 19, 2026 | DEFA14A | Additional annual meeting material | Document |
| May 19, 2026 | 8-K | Shareholder vote | Document |
| Apr 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Apr 27, 2026 | 8-K | Material agreement entered | Document |
| Apr 24, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| Apr 22, 2026 | 8-K | Results of operations | Document |
| Apr 16, 2026 | DEFA14A | Additional annual meeting material | Document |
| Mar 26, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 23, 2026 | DEFA14A | Additional annual meeting material | Document |
| Mar 23, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Mar 23, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 13, 2026 | S-8 | Shares registered for employees | Document |
| Mar 12, 2026 | DEFA14A | Additional annual meeting material | Document |
| Mar 12, 2026 | PRE 14A | Preliminary proxy statement | Document |
| Mar 5, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Feb 26, 2026 | 10-K | Annual reportfor the period to Dec 31, 2025 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Aug 7, 2001.
The full analysis
What do CME's filings show?
The filings are where every one of CME's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.